GLP-1 medications are peptides
S and R stereoisomers are the product of an asymmetric carbon in the molecule
Given the various co-morbidities associated with obesity, including diabetes and cardiovascular disease, intuitively, it would seem that GLP-1 use for weight loss would reduce overall medical costs despite the increase in drug spending
This application is still primarily investigational and is explored within structured clinical protocols
The Akt/PKB signalling pathway regulates numerous cellular processes in the brain including neurogenesis, neuronal differentiation, and synaptic plasticity [137,138,139]
Martin H, Fabian K, Claudia F-T et al (2024) Experimental capture of miRNA targetomes: disease-specific 3UTR library-based miRNA targetomics for Parkinsons disease